You are here

Endothelial Progenitor Cells

Trial Suggests Safety and Efficacy of Endothelial Progenitor Cell Therapy in Chronic Kidney Disease

A phase II clinical trial evaluates the efficacy of CD34-positive EPC treatment in improving renal function and clinical outcomes in chronic kidney disease patients

Systematic Review of Preclinical ECFC Studies

A new review summarizes past progress, the present state, and the future potential of endothelial‐colony forming cell therapy as a stem cell therapy for vascular repair. 

CD34+ Therapy Improves CKD Outcomes

A new STEM CELLS Translational Medicine article from researchers led by Hon‐Kan Yip

Wnt Signaling and EPC Metabolism

Researchers from the labs of Xiao‐rong Li (Tianjin Medical University Eye Hospital, China) and

Trial Results Supports Endothelial Progenitor Cell Therapy for Stroke Patients

The results of a new trial of endothelial progenitor cells suggest improved long-term quality of life and survival in human stroke patients

Stem Cell-derived Extracellular Mitochondria: A New Means to Promote Recovery from Stroke?

A new study demonstrates how human endothelial progenitor cells transfer functional mitochondria to brain endothelial cells to promote recovery from stroke

Quality-Quantity Control Culture Boosts the Wound Healing Ability of Diabetic EPCs

A new report describes how a novel culture system boosts the regenerative properties of diabetic endothelial progenitor cells and improves wound healing

Reprogramming Dysfunctional Endothelial Progenitor Cells with PPARα-laden Microparticles

A new study suggests that PPARα-laden membrane microparticles can reverse loss function of endothelial progenitor cells in a mouse model of metabolic syndrome

New Stem Cell Strategy for Creates Reliable Blood-Brain Barrier Model

The efficient production of specialized endothelial cells from pluripotent stem cells may accelerate the construction of a reliable blood-brain barrier model 

Integrin Overexpression Enhances Stem Cell Treatment of Peripheral Artery Disease

Treatment with ITGB1-modified endothelial cells leads to enhanced migration and improvement in angiogenesis in a mouse model of peripheral artery disease.

Subscribe to RSS - Endothelial Progenitor Cells